Professur für Suchtmedizin

Mitragynine (Kratom)-Induced Cognitive Impairments in Mice Resemble delta 9-THC and Morphine Effects: Reversal by Cannabinoid CB1 Receptor Antagonism (2021) Iman IN, Ahmad NAZ, Yusof NAM, Talib UN, Norazit A, Kumar J, Mehat MZ, et al. Journal article Addiction Research: And the Growing Realization of the Magnitude of the Task (2021) Müller CP Journal article, Editorial Proteomic analysis reveals brain Rab35 as a potential biomarker of mitragynine withdrawal in rats (2021) Hassan R, Othman N, Mansor SM, Müller CP, Hassan Z Journal article Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report (2021) Müller E, Hillemacher T, Müller CP Journal article Pharmacotherapy of schizophrenia: Mechanisms of antipsychotic accumulation, therapeutic action and failure (2021) Chestnykh D, Amato D, Kornhuber J, Müller CP Journal article Sex-Dependent Alcohol Instrumentalization Goals in Non-Addicted Alcohol Consumers versus Patients with Alcohol Use Disorder: Longitudinal Change and Outcome Prediction (2021) Müller CP, Mühle C, Kornhuber J, Lenz B Journal article The effects of chronic mitragynine (Kratom) exposure on the EEG in rats (2021) Suhaimi FW, Hassan Z, Mansor SM, Müller CP Journal article Cross-reinstatement of mitragynine and morphine place preference in rats (2021) Japarin RA, Yusoff NH, Hassan Z, Müller CP, Harun N Journal article Neutral Sphingomyelinase is an Affective Valence-Dependent Regulator of Learning and Memory (2021) Kalinichenko L, Abdel-Hafiz L, Wang AL, Mühle C, Rösel N, Schumacher F, Kleuser B, et al. Journal article Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects (2021) Kalinichenko L, Mühle C, Jia T, Anderheiden F, Datz M, Eberle AL, Eulenburg V, et al. Journal article